SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin‐induced rhabdomyolysis: A case report

We report a case of an adult woman of African ancestry who was hospitalized with statin induced‐ rhabdomyolysis. The patient presented to the emergency room with a 2‐week history of worsening muscle pain, nausea, vomiting and low oral intake, 1 month after starting 40 mg daily dose of rosuvastatin....

Full description

Saved in:
Bibliographic Details
Published in:British journal of clinical pharmacology 2025-01, Vol.91 (1), p.232-235
Main Authors: Medwid, Samantha, Deckert, Rowan, Gryn, Steven E., Kim, Richard B.
Format: Article
Language:English
Subjects:
Adult
Black People - genetics
Case Report
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects
Liver-Specific Organic Anion Transporter 1 - genetics
pharmacogenetics
rhabdomyolysis
Rhabdomyolysis - chemically induced
Rhabdomyolysis - diagnosis
Rhabdomyolysis - genetics
Rosuvastatin Calcium - administration & dosage
Rosuvastatin Calcium - adverse effects
SLCO1B1
statins
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2719-5fe364a3461f9c03b8bed02171f651a37f19940e64a0fd51321451a971d0c0313
container_end_page 235
container_issue 1
container_start_page 232
container_title British journal of clinical pharmacology
container_volume 91
creator Medwid, Samantha
Deckert, Rowan
Gryn, Steven E.
Kim, Richard B.
description We report a case of an adult woman of African ancestry who was hospitalized with statin induced‐ rhabdomyolysis. The patient presented to the emergency room with a 2‐week history of worsening muscle pain, nausea, vomiting and low oral intake, 1 month after starting 40 mg daily dose of rosuvastatin. Sequencing of SLCO1B1 coding regions revealed the patient was heterozygous for two SLCO1B1 deleterious variants, c.481+1G>T and c.1463G>C (*9), which are more prevalent in patients of African ancestry. This highlights the importance of pharmacogenetic testing in SLCO1B1, which includes a broader range of genetic variants for patients of African ancestry.
doi_str_mv 10.1111/bcp.16329
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3128324933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3128324933</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2719-5fe364a3461f9c03b8bed02171f651a37f19940e64a0fd51321451a971d0c0313</originalsourceid><addsrcrecordid>eNp1kcFO3DAQhq0KVLaUAy-AfIRDdj12nGy4oGVV2korUanlbDmOzRpl7WAni3LrI_CMfRJMlyI41BdLM58_j-ZH6BjIFNKZ1aqbQsFo9QFNgBU8o0D5HpoQRoqMUw4H6FOMd4QAg4J_RAes4gDlPJ-g7c_V8houAW9lsNL1EVuHJe5kb7XrsTd4YYJVMhWd0rEPI-6Cjqln3S1-sP0aBx-HrYx9euL-_H60rhmUbnBYy7rxm9G3Y7TxHC-wklHjoDsf-s9o38g26qOX-xDdXH35tfyWra6_fl8uVpmiJVQZN5oVuWR5AaZShNXzWjeEQgmm4CBZaaCqcqITQ0zDgVHIU70qoSEJB3aILnbebqg3ulFp7iBb0QW7kWEUXlrxvuPsWtz6rQAoSmA5SYbTF0Pw90PagNjYqHTbSqf9EAUDOmc0rxhL6NkOVWklMWjz-g8Q8RyUSEGJv0El9uTtYK_kv2QSMNsBD7bV4_9N4nL5Y6d8Auv_nw4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3128324933</pqid></control><display><type>article</type><title>SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin‐induced rhabdomyolysis: A case report</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Medwid, Samantha ; Deckert, Rowan ; Gryn, Steven E. ; Kim, Richard B.</creator><creatorcontrib>Medwid, Samantha ; Deckert, Rowan ; Gryn, Steven E. ; Kim, Richard B.</creatorcontrib><description>We report a case of an adult woman of African ancestry who was hospitalized with statin induced‐ rhabdomyolysis. The patient presented to the emergency room with a 2‐week history of worsening muscle pain, nausea, vomiting and low oral intake, 1 month after starting 40 mg daily dose of rosuvastatin. Sequencing of SLCO1B1 coding regions revealed the patient was heterozygous for two SLCO1B1 deleterious variants, c.481+1G&gt;T and c.1463G&gt;C (*9), which are more prevalent in patients of African ancestry. This highlights the importance of pharmacogenetic testing in SLCO1B1, which includes a broader range of genetic variants for patients of African ancestry.</description><identifier>ISSN: 0306-5251</identifier><identifier>ISSN: 1365-2125</identifier><identifier>EISSN: 1365-2125</identifier><identifier>DOI: 10.1111/bcp.16329</identifier><identifier>PMID: 39511784</identifier><language>eng</language><publisher>England: John Wiley and Sons Inc</publisher><subject>Adult ; Black People - genetics ; Case Report ; Female ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects ; Liver-Specific Organic Anion Transporter 1 - genetics ; pharmacogenetics ; rhabdomyolysis ; Rhabdomyolysis - chemically induced ; Rhabdomyolysis - diagnosis ; Rhabdomyolysis - genetics ; Rosuvastatin Calcium - administration &amp; dosage ; Rosuvastatin Calcium - adverse effects ; SLCO1B1 ; statins</subject><ispartof>British journal of clinical pharmacology, 2025-01, Vol.91 (1), p.232-235</ispartof><rights>2024 The Author(s). published by John Wiley &amp; Sons Ltd on behalf of British Pharmacological Society.</rights><rights>2024 The Author(s). British Journal of Clinical Pharmacology published by John Wiley &amp; Sons Ltd on behalf of British Pharmacological Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2719-5fe364a3461f9c03b8bed02171f651a37f19940e64a0fd51321451a971d0c0313</cites><orcidid>0000-0002-8627-7611 ; 0000-0001-8148-1632</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39511784$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Medwid, Samantha</creatorcontrib><creatorcontrib>Deckert, Rowan</creatorcontrib><creatorcontrib>Gryn, Steven E.</creatorcontrib><creatorcontrib>Kim, Richard B.</creatorcontrib><title>SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin‐induced rhabdomyolysis: A case report</title><title>British journal of clinical pharmacology</title><addtitle>Br J Clin Pharmacol</addtitle><description>We report a case of an adult woman of African ancestry who was hospitalized with statin induced‐ rhabdomyolysis. The patient presented to the emergency room with a 2‐week history of worsening muscle pain, nausea, vomiting and low oral intake, 1 month after starting 40 mg daily dose of rosuvastatin. Sequencing of SLCO1B1 coding regions revealed the patient was heterozygous for two SLCO1B1 deleterious variants, c.481+1G&gt;T and c.1463G&gt;C (*9), which are more prevalent in patients of African ancestry. This highlights the importance of pharmacogenetic testing in SLCO1B1, which includes a broader range of genetic variants for patients of African ancestry.</description><subject>Adult</subject><subject>Black People - genetics</subject><subject>Case Report</subject><subject>Female</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects</subject><subject>Liver-Specific Organic Anion Transporter 1 - genetics</subject><subject>pharmacogenetics</subject><subject>rhabdomyolysis</subject><subject>Rhabdomyolysis - chemically induced</subject><subject>Rhabdomyolysis - diagnosis</subject><subject>Rhabdomyolysis - genetics</subject><subject>Rosuvastatin Calcium - administration &amp; dosage</subject><subject>Rosuvastatin Calcium - adverse effects</subject><subject>SLCO1B1</subject><subject>statins</subject><issn>0306-5251</issn><issn>1365-2125</issn><issn>1365-2125</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kcFO3DAQhq0KVLaUAy-AfIRDdj12nGy4oGVV2korUanlbDmOzRpl7WAni3LrI_CMfRJMlyI41BdLM58_j-ZH6BjIFNKZ1aqbQsFo9QFNgBU8o0D5HpoQRoqMUw4H6FOMd4QAg4J_RAes4gDlPJ-g7c_V8houAW9lsNL1EVuHJe5kb7XrsTd4YYJVMhWd0rEPI-6Cjqln3S1-sP0aBx-HrYx9euL-_H60rhmUbnBYy7rxm9G3Y7TxHC-wklHjoDsf-s9o38g26qOX-xDdXH35tfyWra6_fl8uVpmiJVQZN5oVuWR5AaZShNXzWjeEQgmm4CBZaaCqcqITQ0zDgVHIU70qoSEJB3aILnbebqg3ulFp7iBb0QW7kWEUXlrxvuPsWtz6rQAoSmA5SYbTF0Pw90PagNjYqHTbSqf9EAUDOmc0rxhL6NkOVWklMWjz-g8Q8RyUSEGJv0El9uTtYK_kv2QSMNsBD7bV4_9N4nL5Y6d8Auv_nw4</recordid><startdate>202501</startdate><enddate>202501</enddate><creator>Medwid, Samantha</creator><creator>Deckert, Rowan</creator><creator>Gryn, Steven E.</creator><creator>Kim, Richard B.</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8627-7611</orcidid><orcidid>https://orcid.org/0000-0001-8148-1632</orcidid></search><sort><creationdate>202501</creationdate><title>SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin‐induced rhabdomyolysis: A case report</title><author>Medwid, Samantha ; Deckert, Rowan ; Gryn, Steven E. ; Kim, Richard B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2719-5fe364a3461f9c03b8bed02171f651a37f19940e64a0fd51321451a971d0c0313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Adult</topic><topic>Black People - genetics</topic><topic>Case Report</topic><topic>Female</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects</topic><topic>Liver-Specific Organic Anion Transporter 1 - genetics</topic><topic>pharmacogenetics</topic><topic>rhabdomyolysis</topic><topic>Rhabdomyolysis - chemically induced</topic><topic>Rhabdomyolysis - diagnosis</topic><topic>Rhabdomyolysis - genetics</topic><topic>Rosuvastatin Calcium - administration &amp; dosage</topic><topic>Rosuvastatin Calcium - adverse effects</topic><topic>SLCO1B1</topic><topic>statins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Medwid, Samantha</creatorcontrib><creatorcontrib>Deckert, Rowan</creatorcontrib><creatorcontrib>Gryn, Steven E.</creatorcontrib><creatorcontrib>Kim, Richard B.</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Medwid, Samantha</au><au>Deckert, Rowan</au><au>Gryn, Steven E.</au><au>Kim, Richard B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin‐induced rhabdomyolysis: A case report</atitle><jtitle>British journal of clinical pharmacology</jtitle><addtitle>Br J Clin Pharmacol</addtitle><date>2025-01</date><risdate>2025</risdate><volume>91</volume><issue>1</issue><spage>232</spage><epage>235</epage><pages>232-235</pages><issn>0306-5251</issn><issn>1365-2125</issn><eissn>1365-2125</eissn><abstract>We report a case of an adult woman of African ancestry who was hospitalized with statin induced‐ rhabdomyolysis. The patient presented to the emergency room with a 2‐week history of worsening muscle pain, nausea, vomiting and low oral intake, 1 month after starting 40 mg daily dose of rosuvastatin. Sequencing of SLCO1B1 coding regions revealed the patient was heterozygous for two SLCO1B1 deleterious variants, c.481+1G&gt;T and c.1463G&gt;C (*9), which are more prevalent in patients of African ancestry. This highlights the importance of pharmacogenetic testing in SLCO1B1, which includes a broader range of genetic variants for patients of African ancestry.</abstract><cop>England</cop><pub>John Wiley and Sons Inc</pub><pmid>39511784</pmid><doi>10.1111/bcp.16329</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-8627-7611</orcidid><orcidid>https://orcid.org/0000-0001-8148-1632</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0306-5251
ispartof British journal of clinical pharmacology, 2025-01, Vol.91 (1), p.232-235
issn 0306-5251
1365-2125
1365-2125
language eng
recordid cdi_proquest_miscellaneous_3128324933
source Wiley-Blackwell Read & Publish Collection
subjects Adult
Black People - genetics
Case Report
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects
Liver-Specific Organic Anion Transporter 1 - genetics
pharmacogenetics
rhabdomyolysis
Rhabdomyolysis - chemically induced
Rhabdomyolysis - diagnosis
Rhabdomyolysis - genetics
Rosuvastatin Calcium - administration & dosage
Rosuvastatin Calcium - adverse effects
SLCO1B1
statins
title SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin‐induced rhabdomyolysis: A case report
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A23%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SLCO1B1%20variants%20in%20a%20patient%20of%20African%20ancestry%20presenting%20with%20rosuvastatin%E2%80%90induced%20rhabdomyolysis:%20A%20case%20report&rft.jtitle=British%20journal%20of%20clinical%20pharmacology&rft.au=Medwid,%20Samantha&rft.date=2025-01&rft.volume=91&rft.issue=1&rft.spage=232&rft.epage=235&rft.pages=232-235&rft.issn=0306-5251&rft.eissn=1365-2125&rft_id=info:doi/10.1111/bcp.16329&rft_dat=%3Cproquest_pubme%3E3128324933%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2719-5fe364a3461f9c03b8bed02171f651a37f19940e64a0fd51321451a971d0c0313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3128324933&rft_id=info:pmid/39511784&rfr_iscdi=true